Abstract
In this issue of Clinical Cancer Research , Mutis et al. ([1][1]) use a model of xenogeneic graft-versus-host disease to assess the suppressive function of human regulatory T cells in vivo . This model is based on the transfer of human peripheral blood cells into RAG-2−/−γc−/− mice that are
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical cancer research : an official journal of the American Association for Cancer Research
Paper Title
Journal
Date
